IL-2 treatment after autologous bone marrow transplantation in poor prognosis Hodgkin's disease: defective IL-2-induced LAK activity?

Tiberghien, P

IL-2 treatment after autologous bone marrow transplantation in poor prognosis Hodgkin's disease: defective IL-2-induced LAK activity? [electronic resource] - Bone marrow transplantation 1991 - 145 p. digital

Publication Type: Clinical Trial; Journal Article

0268-3369


Adolescent
Adult
Bone Marrow Transplantation
Child
Combined Modality Therapy
Drug Evaluation
Hodgkin Disease--immunology
Humans
Immunologic Factors--pharmacology
Interleukin-2--pharmacology
Killer Cells, Lymphokine-Activated--drug effects
Killer Cells, Natural--drug effects
Transplantation, Autologous